1Assistant Professor, Department of Pharmacology, SGT Medical College, Hospital and Research Institute, Budhera, Gurugram, Haryana, India
2Professor and Head, Department of Pharmacology, SGT Medical College, Hospital and Research Institute, Budhera, Gurugram, Haryana, India
3Associate Professor, Faculty of Medicine and Health Sciences, SGT Medical College, Hospital and Research Institute, Budhera, Gurugram, Haryana, India
*Corresponding author email id: drshwetasharma26@gmail.com
Online published on 26 October, 2020.
Coronavirus disease 2019 (COVID 19) caused by severe acute respiratory syndrome coronavirus -2 (SARS CoV-2) is spreading all over the world as a pandemic. It has a significant impact on global public health and economies. The biological agents/ vaccines of proven efficacy to treat or prevent this human coronavirus infection are in dire need and are being investigated worldwide. In this article, we review the recent advances in COVID-19, including the response by the host cells, the cytokine release syndrome, and the therapeutic approaches to inhibit the virus and alleviate the cytokine storm.
COVID-19, Drug repurposing, ICMR, Management, SARS CoV-2